Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genfit SA (GNFTF)
OTHER OTC:GNFTF
Holding GNFTF?
Track your performance easily
GNFTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.54 - $6.35
Previous Close$4.39
Volume10.00
Average Volume (3M)711.00
Market Cap
$218.18M
Enterprise Value$209.75M
Total Cash (Recent Filing)€77.79M
Total Debt (Recent Filing)€70.18M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Apr 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding49,834,983
10 Day Avg. Volume0
30 Day Avg. Volume711
Standard Deviation0.21
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)7.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.31Price Target Upside114.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Ownership Overview
0.00%
Insiders
0.18% Mutual Funds
0.04% Other Institutional Investors
99.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GNFTF FAQ
What was Genfit SA’s price range in the past 12 months?
Genfit SA lowest stock price was $2.54 and its highest was $6.35 in the past 12 months.
What is Genfit SA’s market cap?
Currently, no data Available
When is Genfit SA’s upcoming earnings report date?
Genfit SA’s upcoming earnings report date is Apr 10, 2025 which is in 202 days.
How were Genfit SA’s earnings last quarter?
Genfit SA released its earnings results on Sep 19, 2024. The company reported $0.344 earnings per share for the quarter, the consensus estimate of $0.344 by $0.
Is Genfit SA overvalued?
According to Wall Street analysts Genfit SA’s price is currently Undervalued.
Does Genfit SA pay dividends?
Genfit SA does not currently pay dividends.
What is Genfit SA’s EPS estimate?
Genfit SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genfit SA have?
Genfit SA has 49,939,040 shares outstanding.
What happened to Genfit SA’s price movement after its last earnings report?
Genfit SA reported an EPS of $0.344 in its last earnings report, expectations of $0.344. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genfit SA?
Currently, no hedge funds are holding shares in GNFTF
---
Genfit Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.31 (114.52% Upside)
$9.31 (114.52% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.69%
12-Months-Change
Fundamentals
Return on Equity
-35.74%
Trailing 12-Months
Asset Growth
-16.55%
Trailing 12-Months
Company Description
Genfit SA
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné and Bart Staels on September 1999 and is headquartered in Loos, France.
---
GNFTF Earnings Call
Q2 2023
0:00 / 0:00
---
GNFTF Stock 12 Month Forecast
Average Price Target
$9.31
▲(114.52% Upside)
Technical Analysis
Adaptimmune Therapeutics
―
Arrowhead Pharmaceuticals
―
BioCryst
―
Crispr Therapeutics AG
―
Best Analysts Covering GNFTF
1 Year
1 Year Success Rate
12/14 ratings generated profit
1 Year Average Return
+14.20%
reiterated a buy rating 4 days ago
Copying Justine Telliez's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +14.20% per trade.
---